FDA Inspection 1239325 — Triveni Polyclinic
The FDA completed an inspection of Triveni Polyclinic on Mar 8, 2024 in Nagpur. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 8, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nagpur (India)
Additional Details
Clinical BA/BE